Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case 
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand 
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance 
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results 
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue 
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO 
Google Secures Pentagon AI Deal for Classified Projects 
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 
Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition 
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback 
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push 
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 
FBI Warns of China’s Expanding Hack-for-Hire Network Amid Extradition Case 
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek 
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges 
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion 
Fans of wearable devices in more countries might start considering using the Samsung Galaxy Watch 3 or Watch Active 2 as their vital health monitoring features will be available soon. The tech company acquired the necessary permissions for its Health Monitor app to function in a total of 31 countries.
Samsung’s advanced health monitoring services cleared for use in more countries
The Samsung Galaxy Watch 3 and Watch Active 2 are equipped with sensors that allow them to monitor a user’s blood pressure and function with electrocardiogram (ECG) tracking. However, reading this data would require the Samsung Health Monitor app.
Like other health and medical products, the Samsung Health Monitor app needed to be approved in different countries following different regulations. It explains why tech features of this nature typically launch in limited territories. However, this changes for Samsung after the company acquired CE-marking last December for the software product allowing it to launch in European countries.
Samsung Galaxy Watch 3 and Watch Active 2 users Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, and the United Kingdom will soon be able to use the said app for BP and ECG tracking. The app is also launching in Chile, Indonesia, and the UAE making it available in 31 countries after only being accessible in South Korea.
Once the Samsung Health Monitor app goes live in the said countries, Samsung Galaxy Watch 3 and Watch Active 2 have to be updated to their latest versions. Doing so will automatically install the app on the wearable devices. Updates can be initiated through the Galaxy Wearable app via a paired Galaxy smartphone.
Samsung Galaxy Watch 4 rumored to launch with blood sugar level sensor
Having a blood pressure and ECG monitor on people’s wrists through devices like Samsung Galaxy Watch 3 and Watch Active 2 is already a notable technological development. But the company is reportedly looking to add another essential medical tracker in its upcoming Galaxy Watch 4.
ET News reported that Samsung is planning to launch the Galaxy Watch 4 with blood sugar level tracking this year. It is expected to use optic sensors that would allow measure blood glucose levels without blood sampling.
